https://www.selleckchem.com/products/LBH-589.html
The CHIC study (COVID-19 High-intensity Immunosuppression in Cytokine storm syndrome) is a quasi-experimental treatment study exploring immunosuppressive treatment versus supportive treatment only in patients with COVID-19 with life-threatening hyperinflammation. Causal inference provides a means of investigating causality in non-randomised experiments. Here we report 14-day improvement as well as 30-day and 90-day mortality. The first 86 patients (period 1) received optimal supportive care only; the second 86 patients (period 2) receiv
Like
Comment
Share
